Laboratory methods of research of adhesive systems

The aim of our research was to determine the effectiveness of the sealing property of adhesive systems V and VII generations by studying the depth of curing, water absorption and water solubility of their samples. Materials and methods:The study was performed according to ISO / TS 11405: 2015 at the Central Factory Laboratory of JSC “CTOMA”, Kharkiv, Ukraine, Certificate of Attestation No. 100-062 / 2015 dated 03/04/2015. For the study we used specially prepared laboratory samples which were made in the form of plates from adhesive system “DC Adhesive NF” (Dental Central) of V generation “Single bond Universal” (3M ESPE) of VII generation. А monitor and analyze the results obtained used micrometer MK-25, №4694, №03 / 5321 from 08/18/17; caliper SC-1, No. 267447, No. 03/5322 from 08/18/17; scales AP 210, №112144137, №87027 / 9 from 24.11.2017 Results: According to the results of the investigation the following results were obtained: 1) the average curing depth of V and VII generation of adhesive systems was 4.08mm and 3.51mm respectively at the rate of 2mm; 2) average water absorption: 45.97 µg/mm3 and 30.89 µg/mm3 for V and VII generations respectively; 3) the average water solubility was 6.94 µg / mm3 and 4.17 µg / mm3, respectively. Conclusions: According to the results of our laboratory studies, it can be concluded that adhesive systems of V and VII generations can be used for restoration of lesions of tooth hard tissued. Along with this, it can be recommended to use V generation adhesives in closed defects where direct polymerization should be performed and oral fluid access is minimal. Adhesive sysyems of VII generation can be recommended in such cases as: opened restorations, pregingival areas of teeth, cases where a permanent contact of restorations with oral fluid be found along with the cases of autonomic application of adhesive system

ІМУНОТЕРАПІЯ РАКУ ШЛУНКА. НОВІ ДАНІ

Review of the literature 2012-2014 on gastric cancer immunotherapy is presented. Single clinical studies have shown continuing survival of patients with cancers of the stomach for 2-4 months. The method is not out of the stage of clinical experiment.Представлен обзор литературы 2012-2014 гг. по иммунотерапии рака желудка. В редких клинических исследованиях показано продолжение выживаемости больных при распространенных раках желудка на 2-4 месяца. Метод не вышел из стадии клинического эксперимента.Представлений огляд літератури 2012-2014рр. з імунотерапії раку шлунка. У поодиноких клінічних дослідженнях показано продовження виживання хворих при поширених раках шлунка на 2-4 місяці. Метод не вийшов з стадії клінічного експерименту

International comparison of glycaemic control in people with type 1 diabetes: an update and extension

Aims: To update and extend a previous cross-sectional international comparison of glycaemic control in people with type 1 diabetes. Methods: Data were obtained for 520,392 children and adults with type 1 diabetes from 17 population and five clinic-based data sources in countries or regions between 2016 and 2020. Median HbA1c(IQR) and proportions of individuals with HbA1c<58mmol/mol (<7.5%), 58 – 74 mmol/mol (7.5 – 8.9%) and ≥ 75 mmol/mol (≥ 9.0%) were compared between populations for individuals aged <15, 15 – 24 and ≥ 25years. Logistic regression was used to estimate the odds ratio (OR) of HbA1c< 58 mmol/mol (< 7.5%) relative to ≥ 58 mmol/mol (≥ 7.5%), stratified and adjusted for sex, age, and data source. Where possible, changes in the proportion of individuals in each HbA1c category compared to previous estimates were calculated. Results: Median HbA1c varied from 55 to 79 mmol/mol (7.2 to 9.4%) across data sources and age groups so a pooled estimate was deemed inappropriate. OR (95% CI) for HbA1c< 58 mmol/mol (<7.5 %) were 0.91 (0.90 – 0.92) for women compared to men, 1.68 (1.65 – 1.71) for people aged < 15 years and 0.81 (0.79 – 0.82) aged15 – 24 years compared to those aged ≥ 25 years. Differences between populations persisted after adjusting for sex, age, and data source. In general, compared to our previous analysis, the proportion of people with an HbA1c<58 mmol/l (<7.5%) increased and proportions of people with HbA1c≥ 75 mmol/mol (≥ 9.0%) decreased. Conclusions: Glycaemic control of type 1 diabetes continues to vary substantially between age groups and data sources. While some improvement over time has been observed, glycaemic control remains sub-optimal for most people with Type 1 diabetes